Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05744167
Other study ID # LithuanianSportsU-11
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 15, 2022
Est. completion date May 31, 2024

Study information

Verified date December 2023
Source Lithuanian Sports University
Contact Nerijus Masiulis, PhD
Phone +37037302621
Email nerijus.masiulis@lsu.lt
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

BRAIN-M is a randomized controlled trial designed to examine the effects of a single bout or 12 weeks of blood-flow restriction training or high-intensity resistance training on cognitive function, brain health, muscular properties and physical performance in healthy older men 60-75 years old.


Description:

The BRAIN-M project is driven by the idea that understanding the mechanisms through which muscle and brain interact could offer new approaches to magnifying the beneficial and detrimental effects of exercise training on health at older age. Specifically, the investigators aim at identifying brain, blood, and muscle biomarkers that could serve as predictors of response to exercise training at either cognitive, brain, muscle or physical performance levels and study the associations between biomarkers in order to suggest a physiological model of brain-muscle and muscle-brain crosstalk in ageing. 60 male older adults (60-75y old) will be included in either 12 weeks of high-intense blood-flow restriction training (n = 20), muscle damaging resistance training (n = 20) or no exercise (n = 20). The control group will be asked to maintain their usual lifestyle.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date May 31, 2024
Est. primary completion date January 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 60 Years to 75 Years
Eligibility Inclusion Criteria: - healthy male older adults - able to speak and read fluent Lithuanian - living in community during the study Exclusion Criteria: - cognitive and neurological disorders (e.g. dementia, stroke, Parkinson, multiple sclerosis) - previous lower extremity injury - diabetes mellitus type I or II - no oncologic disease - no bone fractures in the previous year - deep vein thrombosis - cardiovascular disorders (e.g. congestive heart failure, angina pectoris, uncontrolled arrhythmia, history of myocardial infarction or coronary bypass grafting in the past year) - obesity (BMI >30kg/m²) - chronic fatigue, chronic headache, or chronic dizziness - ineligibility to MRI scanning (e.g. due to claustrofobia or metal implants) - The participants should not be engaged in any regular exercise programme during the previous 6 months (according to IPAQ), but able to perform 10 sit-ups - Any other consideration that interferes with the study aims and/or risk to the participant, at the discretion of the researcher

Study Design


Intervention

Behavioral:
BFRT
Following a warm-up of 10 min, subjects in the experimental group will undergo BFRT for two times per week, consisting of lower extremity exercises (leg press, knee extension, knee flexion). BFRT will be at 40% of 1 repetition maximum (1RM); The volume % (V% = number of repetitions x number of sets x number of exercises x % 1 repetition max) = 57.6%. Progression during the 12 week program will be attained by a 1RM test every 4 weeks.
MDRT
Following a warm-up of 10 min, subjects in the experimental group will undergo MDRT for two times per week, consisting of lower extremity exercises (leg press, knee extension, knee flexion). The exercise will be at 80% of 1RM concentric-only or 120% of 1RM eccentric-only in a 3:1 ratio. The volume % (V% = number of repetitions x number of sets x number of exercises x % 1 repetition max) = 57.6%. Progression during the 12 week program will be attained by a 1RM test every 4 weeks.

Locations

Country Name City State
Lithuania Lithuanian Sports University Kaunas

Sponsors (7)

Lead Sponsor Collaborator
Lithuanian Sports University KU Leuven, Lithuanian University of Health Sciences, Maastricht University, Research Council of Lithuania, Vrije Universiteit Brussel, Wingate Institute

Country where clinical trial is conducted

Lithuania, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in cognitive function on the Switching task (executive function) The switching task is a complex task where subjects need to switch (executive function) between a manikin task (visuospatial skill, attention and problem solving) and a mathematical computation task (mathematical computation skill, concentration and working memory). Before first exercise bout, immediately after first exercise bout, 1 hour after the first exercise bout and after the 12 week intervention period
Secondary Change in cognitive function on the 2-Choice Reaction time (processing speed), Go/No-Go (inhibition) or 6 letter Memory Search (memory) test Cognitive functioning will be assessed with the Automated Neuropsychological Assessment Metrics 4 (ANAM4) cognitive test battery, testing several cognitive domains. Before first exercise bout, immediately after first exercise bout, 1 hour after the first exercise bout and after the 12 week intervention period
Secondary Changes in lactate levels Capillary lactate levels will be measured in the acute exercise test. Before first exercise bout, immediately after first exercise bout, 1 hour after the first exercise bout
Secondary Changes in blood serum levels of TNFalpha and syndecan We will use enzyme-linked immunosorbent assays (ELISAs) to measure acute changes in TNFalpha, and syndecan before and after the first exercise bout. Before first exercise bout, immediately after first exercise bout, 1 hour after the first exercise bout
Secondary Changes in blood plasma levels of BDNF We will use enzyme-linked immunosorbent assays (ELISAs) to measure acute and chronic changes in BDNF before and after the first exercise bout; and after 12 weeks intervention Before first exercise bout, immediately after first exercise bout, 1 hour after the first exercise bout and after the 12 week intervention period
Secondary Changes in blood serum levels of IGF-1, IL-6 and kynurenine We will use enzyme-linked immunosorbent assays (ELISAs) to measure chronic changes in IGF-1, IL-6 and kynurenine before and after 12 weeks intervention Before and after the 12 week intervention period
Secondary Changes in blood CK levels Blood CK levels will be measured in the MDRT group 48 hours after each eccentric-only training session to assess the muscle damaging effect/repeated bout effect. Before first exercise bout and every 3 weeks for a total of 7 times 48 hours after the eccentric-only training session in the MDRT group.
Secondary Changes in muscle contractile characteristics (with tensiomyography (TMG)) Muscle involuntary contractile characteristics of the lower-limb muscles-the rectus femoris (RF), vastus medialis (VM), vastus lateralis (VL), biceps femoris (BF), semitendinosus (ST), tibialis anterior (TA), gastrocnemius medialis (GM) and gastrocnemius lateralis (GL)-will be recorded by measuring the response of these muscles to an induced electric stimulus (provoked by two self-adhesive electrodes) using TMG equipment on both the left and right lower extremities. Before and after the 12 week intervention period
Secondary Changes in BMI Weight and height will be combined to report BMI in kg/m^2 Before and after the 12 week intervention period
Secondary Changes in body fat % body fat % will be measured using bio-impedance analysis (Tanita) Before and after the 12 week intervention period
Secondary Changes in SMI Skeletal muscle mass index (SMI, kg/m^2) will be measured using bio-impedance analysis (Tanita) Before and after the 12 week intervention period
Secondary Changes in fat free mass Fat free mass (kg) will be measured using bio-impedance analysis (Tanita) Before and after the 12 week intervention period
Secondary Changes in patellar tendon crossectional area Ultrasound will be used to assess the crossectional area (cm^2) of the pattella tendon Before and after the 12 week intervention period
Secondary Changes in patellar tendon stiffness While producing isometric knee extension force, ultrasound will be used to assess patellar tendon distension, which is a measure of tendon stiffness. Before and after the 12 week intervention period
Secondary Changes in quadriceps muscle fascicle length Ultrasound will be used to quantify muscle geometrical properties such as fascicle length (cm). Before and after the 12 week intervention period
Secondary Changes in quadriceps muscle fascicle angle Ultrasound will be used to quantify muscle geometrical properties such as fascicle angle (°). Before and after the 12 week intervention period
Secondary Changes in quadriceps muscle thickness Ultrasound will be used to quantify muscle geometrical properties such as quadriceps muscle thickness. Before and after the 12 week intervention period
Secondary Changes in quadriceps muscle cross-sectional area MRI will be used to measure muscle cross-sectional volume changes of the quadriceps muscles Before and after the 12 week intervention period
Secondary Changes in quadriceps muscle fiber type H-MRS (proton magnetic resonance spectroscopy) will be used to measure fiber type in the quadriceps muscle Before and after the 12 week intervention period
Secondary Changes in quadriceps muscle intramuscular fat H-MRS (proton magnetic resonance spectroscopy) will be used to measure intramuscular fat in the quadriceps muscle Before and after the 12 week intervention period
Secondary Changes in brain gray matter volume (with magnetic resonance imaging) MRI will be used to measure changes in gray matter volume using T1 images Before and after the 12 week intervention period
Secondary Changes in brain white matter volume (with magnetic resonance imaging) MRI will be used to measure changes in white matter integrity using DTI sequence Before and after the 12 week intervention period
Secondary Changes in brain neural integrity (with proton magnetic resonance spectroscopy) H-MRS will be used to measure changes in N-acetylaspartate levels in specific brain regions: right dorsolateral prefrontal cortex, left hippocampus and left primary sensorimotor cortex. Before and after the 12 week intervention period
Secondary Changes in brain neuroinflammation (with proton magnetic resonance spectroscopy) H-MRS will be used to measure changes in myo-inositol levels in specific brain regions: right dorsolateral prefrontal cortex, left hippocampus and left primary sensorimotor cortex. Before and after the 12 week intervention period
Secondary Changes in brain neuroplasticity marker (with proton magnetic resonance spectroscopy) H-MRS will be used to measure changes in Glx in specific brain regions: right dorsolateral prefrontal cortex, left hippocampus and left primary sensorimotor cortex. Before and after the 12 week intervention period
Secondary Changes in balance (with posturography on Kistler platform) Balance will be assessed in four different positions (two legs stance vs Romberg stance with eyes open vs closed) with or without a cognitive task to measure dual task effects. Before and after the 12 week intervention period
Secondary Changes in handgrip strength Handgrip strength will be measured using Jamar dynamometry Before and after the 12 week intervention period
Secondary Changes in maximal isometric strength (with Biodex) Knee extension/flexion maximal isometric strength (N) will be measured using Biodex. Before and after the 12 week intervention period
Secondary Changes in isokinetic peak torque (with Biodex) Knee extension/flexion isokinetic peak torque measurements will be done at 60°/s Before and after the 12 week intervention period
Secondary Changes in rate of force development (with Biodex) Rate of force development will be measured during maximal knee extension/flexion movement. Before and after the 12 week intervention period
Secondary Changes in physical performance (with the Fitness Fullerton Test battery for the Senior) Determination of motor control tasks relevant to daily life activities. A selection of tests, including the sit-to-stance test, timed up-and-go test, and other physical tests Before and after the 12 week intervention period
Secondary Changes in subjective quality of life (patient reported outcome questionnaires) Quality of life will be assessed using the World Health Organisation 100 (WHO 100) questionnaire Before and after the 12 week intervention period
Secondary Changes in nutrition (patient reported outcome questionnaires) We will use a selection of patient reported outcome measures to evaluate their nutrition (using the Actual nutrition registration questionnaire). Before and after the 12 week intervention period
Secondary Changes in subjective sleep quality (patient reported outcome questionnaires) We will use a selection of patient reported outcome measures to evaluate their quality of sleep (using the Stanford sleep quality scale). Before and after the 12 week intervention period
Secondary Changes in reported physical activity levels (patient reported outcome questionnaires) We will assess physical activity levels using the International Physical Activities Questionnaire (IPAQ) Before and after the 12 week intervention period
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A